NIAID Now
5 Results
New NIAID Study Examines Immune Responses in People Hospitalized with COVID-19
May 01, 2020
Today, a new NIAID-supported study has begun to track the immune responses of people hospitalized with COVID-19 in 10 research sites across the United States. Data collected in the IMPACC study will help inform recommendations for COVID-19 care and, hopefully, identify new targets and optimal timing for experimental treatments.
Prickly Patch Delivery of Experimental COVID-19 Vaccine Shows Promise in Animal Study
April 03, 2020
A candidate vaccine delivered though a thumbnail-sized patch studded with microneedles could help address the coronavirus disease 2019 (COVID-19) pandemic.
Rapidly Share, Discover, and Cite COVID-19 Research Results Generated by NIAID Awards
March 23, 2020
NIAID has a vision for a modernized, integrated biomedical data ecosystem as outlined in the NIH Strategic Plan for Data Science. To support this goal, it is critical to enhance data-sharing and access and to have NIAID-funded data be findable, accessible, interoperable, and reusable (FAIR).
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
February 19, 2020
NIAID scientists and investigators from UT Austin identified the atomic structure of an important protein on the surface of the novel coronavirus.
New Images of Novel Coronavirus SARS-CoV-2 Now Available
February 13, 2020
NIAID has produced images of the novel coronavirus SARS-CoV-2 on its scanning and transmission electron microscopes on Tuesday, Feb. 11, 2020. SARS-CoV-2 causes COVID-2019 disease, which has grown to be a global public health emergency since cases were first detected in Wuhan, China, in December 2019.